CD4 and tuberculosis: Additionally, the clinical cure of tuberculosis led to a greater repertoire of CD4+ T cells activated by soluble antigens derived from M. bovis, demonstrating the potential of these antigens to stimulate a specific response due to prior development of tuberculosis, contact with mycobacteria without development of disease, or BCG vaccination, which is widely administered in the study region.